The inaugural Longevity Therapeutics 2019 will bring together the leading biotech drug developers, academics, investors and pharma companies endeavoring to develop innovative therapies targeting age-related conditions.
Join them to collaboratively tackle specific challenges faced to develop these therapies – from discovery, to preclinical activities, translational research, clinical development, regulatory and commercial considerations – and uncover the details behind the latest developments in this space.
Early Rate: USD 1799.0
Standard Rate: USD 2099.0
Speakers: Aubrey de Grey - AgeX Therapeutics, Judith Campisi - Buck Institute for Research on Aging, Nathaniel David - Unity Biotechnology, Nir Barzilai - Albert Einstein College of Medicine, Samuel Agus - Biophytis, Steven Braithwaite - Alkahest Inc., Ronald Kohanski - National Institute on Aging, NIH, Mark Bamberger - Stealth BioTherapeutics, Marc Ramis-Castelltort - Senolytic Therapeutics Inc., Lorna Harries - University of Exeter Medical School, Lindsay Wu - UNSW Sydney, Life Biosciences, Kristen Fortney - BioAge Labs, Kelsey Moody - Antoxerene/Ichor Therapeutics
Time: 8:00 am - 5:00 pm
Registration Website: http://go.evvnt.com/286192-1?pid=4870
Submitted by Love Evvnt, Evvnt on Tuesday, 29 January 2019 at 8:00 AM
|Event Date: ||29 January 2019 - 31 January 2019
||Contact Person: ||Customer Services
|Venue: ||Argonaut Hotel, 495 Jefferson Street, San Francisco, 94109
|Country: ||United States
Category: Health Care & Medical
Brought to you by Scoopasia [http://scoopasia.com]